[go: up one dir, main page]

PT3193887T - Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions - Google Patents

Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions

Info

Publication number
PT3193887T
PT3193887T PT158342360T PT15834236T PT3193887T PT 3193887 T PT3193887 T PT 3193887T PT 158342360 T PT158342360 T PT 158342360T PT 15834236 T PT15834236 T PT 15834236T PT 3193887 T PT3193887 T PT 3193887T
Authority
PT
Portugal
Prior art keywords
xanthan gum
suspending agent
oral pharmaceutical
agent including
konjac powder
Prior art date
Application number
PT158342360T
Other languages
Portuguese (pt)
Original Assignee
Professional Compounding Centers Of America Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Professional Compounding Centers Of America Ltd filed Critical Professional Compounding Centers Of America Ltd
Publication of PT3193887T publication Critical patent/PT3193887T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
PT158342360T 2014-08-20 2015-08-20 Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions PT3193887T (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462039771P 2014-08-20 2014-08-20
US14/830,500 US9737609B2 (en) 2014-08-20 2015-08-19 Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions

Publications (1)

Publication Number Publication Date
PT3193887T true PT3193887T (en) 2020-09-28

Family

ID=55347356

Family Applications (1)

Application Number Title Priority Date Filing Date
PT158342360T PT3193887T (en) 2014-08-20 2015-08-20 Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions

Country Status (7)

Country Link
US (1) US9737609B2 (en)
EP (1) EP3193887B1 (en)
AU (1) AU2015305510B2 (en)
CA (1) CA2958925C (en)
ES (1) ES2822558T3 (en)
PT (1) PT3193887T (en)
WO (1) WO2016028968A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2660294T3 (en) 2013-03-12 2018-03-21 Panacea Biomatx Inc. Method and system to make custom formulations for individuals
US9737609B2 (en) 2014-08-20 2017-08-22 Professional Compounding Centers Of America (Pcca) Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions
WO2017075463A1 (en) * 2015-10-30 2017-05-04 Cmp Development Llc Spironolactone aqueous compositions
US10493083B2 (en) 2015-10-30 2019-12-03 Cmp Development Llc Spironolactone aqueous compositions
ITUA20163937A1 (en) * 2016-05-30 2017-11-30 Pharcoterm S R L Vehicle for the administration of active ingredients and / or functional ingredients, and compositions containing the same.
EP3471725B1 (en) 2016-06-16 2025-02-19 Azurity Pharmaceuticals, Inc. Composition and method for proton pump inhibitor suspension
CA3036356A1 (en) * 2016-09-09 2018-03-15 Cutispharma, Inc. Suspensions and diluents for metronidazole and baclofen
WO2019070818A2 (en) * 2017-10-04 2019-04-11 Panacea Biomatx, Inc. Suspensions of encapsulated pharmaceuticals and methods of making and using the same
DE202018000323U1 (en) 2018-01-22 2018-04-03 AVOXA - Mediengruppe Deutscher Apotheker GmbH Solution and suspension basis
US11633478B2 (en) 2019-07-16 2023-04-25 Azurity Pharmaceuticals, Inc. Compositions and kits for Omeprazole suspension
US10751333B1 (en) 2019-07-16 2020-08-25 Cutispharma, Inc. Compositions and kits for omeprazole suspension
US12138333B2 (en) 2020-04-10 2024-11-12 The Procter & Gamble Company Rheological solid composition for use in personal care compositions
EP4133048A1 (en) 2020-04-10 2023-02-15 The Procter & Gamble Company Cleaning implement with a rheological solid composition
WO2021207436A1 (en) * 2020-04-10 2021-10-14 The Procter & Gamble Company Rheological solid composition for use in shaving
WO2021207439A1 (en) 2020-04-10 2021-10-14 The Procter & Gamble Company Rheological solid composition
CA3176561A1 (en) * 2020-04-10 2021-10-14 The Procter & Gamble Company Structured rheological solid personal care compositions
US12122979B2 (en) 2020-04-10 2024-10-22 The Procter & Gamble Company Cleaning article with preferential rheological solid composition
CN116440074B (en) * 2023-05-26 2024-02-20 浙江高跖医药科技股份有限公司 Potassium chloride oral preparation and preparation method thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2661091B1 (en) 1990-04-18 1994-10-21 Andre Salkin USE OF HEXETIDINE OR ITS DERIVATIVES OR SALTS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR OPHTHALMOLOGICAL USE.
GB2363386B (en) 2000-06-16 2004-07-28 Chesham Chemicals Ltd Fluid gel comprising xanthan and non-gelling polysaccharides
US20020019447A1 (en) 2000-07-03 2002-02-14 Renn Donald Walter Physical forms of clarified hydrocolloids of undiminished properties and method of producing same
WO2007117605A2 (en) * 2006-04-06 2007-10-18 Taro Pharmaceuticals North America, Inc. Novel spill-resistant formulations comprising hydrocolloidal polymers
EP2037941B8 (en) * 2006-05-30 2015-07-01 OraHealth Corporation Cobalamin compositions for treating or preventing mucositis
WO2008056786A1 (en) * 2006-11-10 2008-05-15 Rohto Pharmaceutical Co., Ltd. Composition for skin or mucosal application
DE102007047608A1 (en) * 2007-10-04 2009-04-09 Grünenthal GmbH 19-nor-progesterone for contraception
EP2672838A1 (en) * 2011-02-08 2013-12-18 McNeil Nutritionals, LLC Enhanced natural sweetener and method of making
JP5597770B2 (en) * 2011-04-20 2014-10-01 サフン カプセル カンパニー, リミテッド Non-animal soft capsule coating composition with improved disintegration and coating hardness
AU2013235266B2 (en) 2012-03-20 2017-10-19 Particle Dynamics International, Llc Gelling agent-based dosage form
CA2791206A1 (en) 2012-09-28 2014-03-28 Pharmascience Inc. Abuse deterrent pharmaceutical formulation
WO2014089174A2 (en) 2012-12-06 2014-06-12 Aerodesigns, Inc. Aerosol dispenser with edible cartridge
US9737609B2 (en) 2014-08-20 2017-08-22 Professional Compounding Centers Of America (Pcca) Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions

Also Published As

Publication number Publication date
EP3193887A1 (en) 2017-07-26
US9737609B2 (en) 2017-08-22
US20160051684A1 (en) 2016-02-25
CA2958925C (en) 2020-11-24
AU2015305510B2 (en) 2019-08-22
EP3193887B1 (en) 2020-09-09
AU2015305510A1 (en) 2017-03-23
CA2958925A1 (en) 2016-02-25
ES2822558T3 (en) 2021-05-04
EP3193887A4 (en) 2018-05-30
WO2016028968A1 (en) 2016-02-25

Similar Documents

Publication Publication Date Title
PT3193887T (en) Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions
IL258082B (en) Bezimidazole derivatives and pharmaceutical compositions containing them
ZA201704985B (en) Oral care compositions and methods of use
IL252602B (en) Oral care compositions and methods of use
EP3110427A4 (en) Compositions of pentosan polysulfate salts for oral administration and methods of use
HK1252113A1 (en) New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them
IL240290B (en) Pyridazinone-amides derivatives and pharmaceutical compositions containing them
IL259239B (en) Oral care compositions and methods
IL249803A0 (en) Azepanyl derivatives and pharmaceutical compositions containing them
ZA201701487B (en) Powder oral suspension formulations of antibacterial agents
IL250267A0 (en) Indolizine derivatives, their preparation and pharmaceutical compositions containing them
ZA201703562B (en) Pharmaceutical composition for oral administration comprising taxane
IL249308A0 (en) Quinoline derivatives their preparation, and pharmaceutical compositions containing them
IL243227B (en) Diaminocyclopentane carboxamide derivatives, their preparation and pharmaceutical compositions containing them
SG11201701453QA (en) Oral composition containing bifidobacteria and cruciferous vegetable
EP3145508C0 (en) Clevidipine nanoparticles and pharmaceutical compositions thereof
IL241513A0 (en) Piperazine derivatives their preparation and pharmaceutical compositions containing them
HK1232144A1 (en) Pharmaceutical composition for oral administration
IL250394B (en) Oral composition for delivery of drugs and other substances
PT3169311T (en) Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof
IL252080B (en) Oral administration of unstable or poorly-absorbed drugs